<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND &amp; AIMS: Increasing evidence points towards a role of <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C virus (HCV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in causing malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We pooled case-control study data to provide robust estimates of the risk of non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) subtypes after HCV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The analysis included 7 member studies from the International <z:hpo ids='HP_0002665'>Lymphoma</z:hpo> Epidemiology Consortium (InterLymph) based in Europe, North America, and Australia </plain></SENT>
<SENT sid="3" pm="."><plain>Adult cases of NHL (n = 4784) were diagnosed between 1988 and 2004 and controls (n = 6269) were matched by age, sex, and study center </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> studies used third-generation enzyme-linked immunosorbent assays to test for antibodies against HCV in serum samples </plain></SENT>
<SENT sid="5" pm="."><plain>Participants who were human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus positive or were organ-transplant recipients were excluded </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: HCV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was detected in 172 NHL cases (3.60%) and in 169 (2.70%) controls (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.40-2.25) </plain></SENT>
<SENT sid="7" pm="."><plain>In subtype-specific analyses, HCV prevalence was associated with marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (OR, 2.47; 95% CI, 1.44-4.23), diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (OR, 2.24; 95% CI, 1.68-2.99), and lymphoplasmacytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (OR, 2.57; 95% CI, 1.14-5.79) </plain></SENT>
<SENT sid="8" pm="."><plain>Notably, risk estimates were not increased for follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (OR, 1.02; 95% CI, 0.65-1.60) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: These results confirm the association between HCV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and NHL and specific B-NHL subtypes (diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and lymphoplasmacytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>) </plain></SENT>
</text></document>